@felipep41636281@MeetThePress If he'd said he was a drug addict then there wouldn't have been a case. The defamation was saying he asked Iran for a bribe in exchange for official action.
@KarlWilfred@atrupar Y'all made the same argument about Mark Robinson in NC... who then dropped the case before discovery and then later admitted it was all true.
@The_First_75@MeanTweetsRule@Eggman85@PeteHegseth@KidRock@USArmy He asked for unity, quoting Renee Good saying "I'm not mad at you", contrasted with trump saying he has ill wishes for those who are his opponents. Said this nation was founded on disagreement and we've been disagreeing for hundreds of years and that is what makes us great.
This is precisely the kind of government coercion that the First Amendment was designed to prevent — and media companies need to start standing up rather than capitulating to it. https://t.co/gOjqFnGv0I
After years of complaining about cancel culture, the current administration has taken it to a new and dangerous level by routinely threatening regulatory action against media companies unless they muzzle or fire reporters and commentators it doesn’t like. https://t.co/uts7JpJZzN
"Involuntary lethal injection - just kill them" cannot possibly be a mainstream solution to homelessness and schizophrenia. And yet @FoxNews personality Brian Kilmeade proposed it on live TV and still has a job.
This is vile Nazi rhetoric.
My friend Smita just boarded a plane for Spain! She's off to get her MBA and will be the first girl from her community with a grad school degree, especially one from abroad! https://t.co/je7DDhZF1d
We are thrilled to announce that the 3.8 Initiative has expanded to WIB-RTP! The kickoff event was a huge success — congratulations to the 13 participants selected!
You can read more about the program and find the press release on our website. https://t.co/AAFbnvCvSu
Did you set a reminder yet? 👀 👉🏾🗓 Please join us tomorrow at 3 PM eastern time for a candid conversation about the costs of living with a chronic illness. It’s our last #LupusChat before our summer break. We don’t want you to miss it!
We're excited to announce the 2022 #PrixGalien USA nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent” and “Best Medical Technology” categories are now live! Find out more: https://t.co/gIltasV9cf